All In Biotech

Drug Trial Radar · NCT07762170

Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)

Success Rates and Safety in Managing Spinal and Sacro-Iliac Pain: A Critical Analysis

Last checked: Nov 20, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Jul 30, 2026

Primary completion

Dec 2029

Study completion Mar 2030

Sponsor

Lead sponsor
Igor Wilderman. MDAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 13, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to analyze the efficacy and safety of different kinds of steroid injections for back pain, comparing different steroids, dosages, locations (epidural, facet joints, nerve blocks), and also the difference between injections with steroids and local anesthetics, to optimize this treatment that is currently not standardized. The investigators will compare retrospectively and prospectively the efficacy of different injections in the same patients, using mainly a parameter called integral of pain relief, which combines the percentage of pain relief provided by a treatment and its duration over time, as well as improvements in functionality.

Conditions

  • Back Pain Lower Back
  • Neck Pain
  • Radiculopathy Multiple Sites
  • Spinal Stenosis Cervicothoracic Region
  • Spinal Stenosis Lumbar
  • Failed Back Surgery Syndrome (FBSS)
  • Sciatica
  • Intervertebral Disc Disorders With Radiculopathy, Lumbar Region
  • Spine Osteoarthritis

Interventions

  • triamcinolone acetonide (Kenalog)Drug

    Comparison of efficacy and safety of various protocols of injections for back pain

  • Celestone Soluspan 6Mg/Ml Suspension for InjectionDrug

    Comparison of efficacy and safety of various protocols of injections for back pain

  • Depo-Medrol 40Mg/Ml Suspension for InjectionDrug

    Comparison of efficacy and safety of various protocols of injections for back pain

  • DexamethasoneDrug

    Comparison of efficacy and safety of various protocols of injections for back pain

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Integral of pain reliefTime frame: 8-12 weeks, up to 6 months or one year if applicable
  2. Numeric rating scaleTime frame: 2, 4, 6, 8, 12 weeks
  3. Functional integral of pain reliefTime frame: 8-12 weeks, up to 6 months or one year if applicable
  4. Patient-Reported Outcomes Measurement Information System (PROMIS) questionnaire - custom versionTime frame: 2, 4, 6, 8, 12 weeks
  5. Patient's global impression of change (PGIC)Time frame: 2, 4, 6, 8, 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Wilderman Medical Clinic

    Thornhill, Ontario, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.